Latest filing published 09 May 2018 for AMYRIS, INC., €522k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Maxwell (Mauritius) Pte Ltd: trading record in brief
Maxwell (Mauritius) Pte Ltd discloses dealings in 2 companies, chiefly Amyris, Inc. and Portola Pharmaceuticals Inc. Between 28 May 2013 and 7 May 2018, the trades on record add up to 80 filings.
Market trades split into 2 purchases (€40.5M) and 73 sales (€65.4M). The net balance comes to €24.8M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 3 share grants. In 2018 alone, the filings show no purchases and 1 sale.
On 9 May 2018 came the latest disclosure, an open-market sale for €522k in Amyris, Inc. The latest purchase dates back some time: it was published 4,414 days ago, on 8 October 2014. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Maxwell (Mauritius) Pte Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 95,162 shares@ US$6.54293.9% of flowCommon StockSEC:0000899243-18-012036:0
- 1,700,000 shares@ US$34.40100.0% of flowCommon stockSEC:0000899243-17-015234:0
- 338,864 shares@ US$0.58561.4% of flowCommon StockSEC:0000899243-17-010671:0
- 313,649 shares@ US$0.51281.1% of flowCommon StockSEC:0000899243-17-010671:1
- 937,225 shares@ US$0.68314.5% of flowCommon StockSEC:0000899243-17-010505:0
- 699,705 shares@ US$0.60743.0% of flowCommon StockSEC:0000899243-17-010505:1
- 184,535 shares@ US$0.5120.7% of flowCommon StockSEC:0000899243-17-009072:0
- 117,520 shares@ US$0.48430.4% of flowCommon StockSEC:0000899243-17-008874:0
- 300,470 shares@ US$0.5181.1% of flowCommon StockSEC:0000899243-17-008874:1
- 42,446 shares@ US$0.4840.1% of flowCommon StockSEC:0000899243-17-008742:0
- 86,613 shares@ US$0.4840.3% of flowCommon StockSEC:0000899243-17-008742:1
- 121,946 shares@ US$0.47460.4% of flowCommon StockSEC:0000899243-17-008462:0
- 43,482 shares@ US$0.48550.1% of flowCommon StockSEC:0000899243-17-008462:1
- 134,691 shares@ US$0.48020.5% of flowCommon StockSEC:0000899243-17-008328:1
- 88,382 shares@ US$0.4910.3% of flowCommon StockSEC:0000899243-17-008328:0
- 186,800 shares@ US$0.48760.6% of flowCommon StockSEC:0000899243-17-008171:0
- 153,108 shares@ US$0.49340.5% of flowCommon StockSEC:0000899243-17-008171:1
- 139,170 shares@ US$0.45960.5% of flowCommon StockSEC:0000899243-17-007704:1
- 131,204 shares@ US$0.46940.4% of flowCommon StockSEC:0000899243-17-007704:0
- 164,773 shares@ US$0.49460.6% of flowCommon StockSEC:0000899243-17-007396:0
- 181,656 shares@ US$0.50930.7% of flowCommon StockSEC:0000899243-17-007396:1
- 321,278 shares@ US$0.47071.1% of flowCommon StockSEC:0000899243-17-007104:1
- 199,647 shares@ US$0.43360.6% of flowCommon StockSEC:0000899243-17-007104:0
- 338,683 shares@ US$0.46931.1% of flowCommon StockSEC:0000899243-17-006776:0
- 513,541 shares@ US$0.43561.6% of flowCommon StockSEC:0000899243-17-006776:1
25 of 80 declarations
